ABEO Abeona Therapeutics Inc.

NASDAQ
$2.60

Abeona Therapeutics Inc. (ABEO) Earnings News

Earnings press releases, previews and reviews for Abeona Therapeutics Inc. (ABEO), newest first. Our most recent is review: Abeona Beats on EPS but Misses Revenue by 25% as the ZEVASKYN Ramp Slows and the Company Adds an EoE Asset.